Does ISATUXIMAB Cause Hepatic function abnormal? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Hepatic function abnormal have been filed in association with ISATUXIMAB (Sarclisa). This represents 0.4% of all adverse event reports for ISATUXIMAB.
14
Reports of Hepatic function abnormal with ISATUXIMAB
0.4%
of all ISATUXIMAB reports
1
Deaths
10
Hospitalizations
How Dangerous Is Hepatic function abnormal From ISATUXIMAB?
Of the 14 reports, 1 (7.1%) resulted in death, 10 (71.4%) required hospitalization, and 8 (57.1%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ISATUXIMAB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does ISATUXIMAB Cause?
Neutropenia (396)
Pneumonia (304)
Covid-19 (248)
Plasma cell myeloma (241)
Thrombocytopenia (227)
Infusion related reaction (213)
Pyrexia (202)
Anaemia (197)
Diarrhoea (162)
Off label use (126)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which ISATUXIMAB Alternatives Have Lower Hepatic function abnormal Risk?
ISATUXIMAB vs ISATUXIMAB-IRFC
ISATUXIMAB vs ISAVUCONAZOLE
ISATUXIMAB vs ISAVUCONAZONIUM
ISATUXIMAB vs ISCALIMAB
ISATUXIMAB vs ISENTRESS